About BioTechniques
Year of la
unch: 1983
ISSN (print): 0736-6205 | ISSN (online): 1940-9818
Frequency: 12 issues per year – Impact Factor: 2.746 (2021)
Established in 1983, BioTechniques was founded on two ground-breaking and inspired principles:
First, and most critically, seeing the need for a journal to properly communicate methods, techniques and new instrumentation to those researchers working in the lab, BioTechniques was the first publication to feature peer-reviewed, primary research articles focused on methods and techniques – focusing not only on cutting edge methods and technologies, but also on those used in the ‘common lab’ on a day-to-day basis. As such, BioTechniques is not only read but used by its audience at the bench.
The second transformational concept BioTechniques applied was an open-access model of publishing – therefore being one of the first open-access scholarly journals in the life sciences. This enabled wide distribution of content, initially as a print publication and now as an online-first proposition.
BioTechniques.com: Complementing the journal
On BioTechniques.com, we provide the opportunity to join our global community of lab researchers, industry experts and budding scientists. BioTechniques.com provides access to regular updates of our journal content with issue highlight pieces, Peek behind the paper interviews and etoc alerts.
What’s more, we understand that keeping up with science is about more than just publications, which is why we provide intriguing news, informative videos, infographics, eBooks and engaging podcasts for members to enjoy on their coffee break or on the go. Covering the latest in the life sciences, beyond the methods, through to their applications and impacts, our editors and partners aim to ensure that following BioTechniques.com means staying up to date with the hottest topics in the life sciences.
Awards
BioTechniques has been listed as a finalist for the PPA Special Interest Magazine/Brand of the Year Award 2022! The PPA awards recognize, celebrate and elevate the achievements and progress made across the UK publishing and media industry.
We have also been listed as a finalist for the AOP Digital Publishing Best Online Brand: B2B Award 2022! The award celebrates the innovative thinking that is so important to the digital puiblishing industry.
BioTechniques is a property of Taylor & Francis. Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.
Our 2,500+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies.
Taylor & Francis is proud to be a Global Certified Accessible™ publisher and our operations and all our print publications are certified CarbonNeutral®.
